Literature DB >> 16709153

Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.

Ignacio Rubio1, Knut Rennert, Ute Wittig, Katrin Beer, Matthias Dürst, Stacey L Stang, Jim Stone, Reinhard Wetzker.   

Abstract

Ras is a major mediator of PE (phorbol ester) effects in mammalian cells. Various mechanisms for PE activation of Ras have been reported [Downward, Graves, Warne, Rayter and Cantrell (1990) Nature (London) 346, 719-723; Shu, Wu, Mosteller and Broek (2002) Mol. Cell. Biol. 22, 7758-7768; Roose, Mollenauer, Gupta, Stone and Weiss (2005) Mol. Cell. Biol. 25, 4426-4441; Grosse, Roelle, Herrlich, Höhn and Gudermann (2000) J. Biol. Chem. 275, 12251-12260], including pathways that target GAPs (GTPase-activating proteins) for inactivation and those that result in activation of GEFs (guanine nucleotide-exchange factors) Sos (son of sevenless homologue) or RasGRP (RAS guanyl releasing protein). However, a biochemical link between PE and GAP inactivation is missing and GEF stimulation is hard to reconcile with the observation that dominant-negative S17N-Ras does not compromise Ras-dependent ERK (extracellular-signal-regulated kinase) activation by PE. We have addressed this controversy and carried out an in-depth biochemical study of PE-induced Ras activation in COS-7 cells. Using a cell-permeabilization approach to monitor nucleotide exchange on Ras, we demonstrate that PE-induced Ras-GTP accumulation results from GEF stimulation. Nucleotide exchange stimulation by PE is prevented by PKC (protein kinase C) inhibition but not by EGFR [EGF (epidermal growth factor) receptor] blockade, despite the fact that EGFR inhibition aborts basal and PE-induced Shc (Src homology and collagen homology) phosphorylation and Shc-Grb2 (growth-factor-receptor-bound protein 2) association. In fact, EGFR inhibition ablates basal nucleotide exchange on Ras in growth-arrested COS-7 cells. These data disclose the existence of two separate GEF systems that operate independently from each other to accomplish PE-dependent formation of Ras-GTP and to maintain resting Ras-GTP levels respectively. We document that COS-7 cells do not express RasGRP and present evidence that the PE-responsive GEF system may involve PKC-dependent phosphorylation of Sos. More fundamentally, these observations shed new light on enigmatic issues such as the inefficacy of S17N-Ras in blocking PE action or the role of the EGFR in heterologous agonist activation of the Ras/ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709153      PMCID: PMC1550314          DOI: 10.1042/BJ20060160

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

1.  RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs.

Authors:  J O Ebinu; D A Bottorff; E Y Chan; S L Stang; R J Dunn; J C Stone
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

2.  Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction.

Authors:  N Chen; W Y Ma; Q B She; E Wu; G Liu; A M Bode; Z Dong
Journal:  J Biol Chem       Date:  2001-10-09       Impact factor: 5.157

3.  beta-Migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation.

Authors:  D Zhao; J Letterman; B M Schreiber
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

4.  Phorbol esters modulate the Ras exchange factor RasGRP3.

Authors:  P S Lorenzo; J W Kung; D A Bottorff; S H Garfield; J C Stone; P M Blumberg
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  RasGRP4, a new mast cell-restricted Ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients and demonstration of the importance of RasGRP4 in mast cell development and function.

Authors:  Yi Yang; Lixin Li; Guang W Wong; Steven A Krilis; M S Madhusudhan; Andrej Sali; Richard L Stevens
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

6.  Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo.

Authors:  Tzu-Ching Meng; Toshiyuki Fukada; Nicholas K Tonks
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

7.  Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3.

Authors:  Christine Teixeira; Stacey L Stang; Yong Zheng; Naomi S Beswick; James C Stone
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

8.  Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.

Authors:  Albrecht Piiper; Robert Elez; Se-Jong You; Bernd Kronenberger; Stefan Loitsch; Serge Roche; Stefan Zeuzem
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

9.  Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.

Authors:  Xiaodong Shu; Weicheng Wu; Raymond D Mosteller; Daniel Broek
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

10.  Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC.

Authors:  Francesc Tebar; Anna Lladó; Carlos Enrich
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

View more
  6 in total

1.  Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.

Authors:  Silvia Ginés; Paola Paoletti; Jordi Alberch
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

2.  Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells.

Authors:  Daniela A Eisinger; Hermann Ammer
Journal:  J Biol Chem       Date:  2009-10-14       Impact factor: 5.157

3.  Lysophosphatidylcholine Drives Neuroblast Cell Fate.

Authors:  Luciana Paoletti; Pablo Domizi; Hebe Marcucci; Aneley Montaner; Dario Krapf; Gabriela Salvador; Claudia Banchio
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

4.  RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines.

Authors:  O Ksionda; A A Melton; J Bache; M Tenhagen; J Bakker; R Harvey; S S Winter; I Rubio; J P Roose
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

Review 5.  Regulation of ras exchange factors and cellular localization of ras activation by lipid messengers in T cells.

Authors:  Jesse E Jun; Ignacio Rubio; Jeroen P Roose
Journal:  Front Immunol       Date:  2013-09-04       Impact factor: 7.561

6.  JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin.

Authors:  Karmveer Singh; Emanuela Camera; Linda Krug; Abhijit Basu; Rajeev Kumar Pandey; Saira Munir; Meinhard Wlaschek; Stefan Kochanek; Marina Schorpp-Kistner; Mauro Picardo; Peter Angel; Catherin Niemann; Pallab Maity; Karin Scharffetter-Kochanek
Journal:  Nat Commun       Date:  2018-08-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.